NET of unknown primary
Revision as of 21:40, 1 May 2023 by Warner-admin (talk | contribs) (Text replacement - "5 PubMed" to "5/ PubMed")
0 regimens on this page
0 variants on this page
|
Guidelines
ESMO
- 2015: Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up PubMed
NCCN
All lines of therapy
- Poorly differentiated or small cell tumors can be treated with small cell lung cancer regimens.
- Moderate to well-differentiated neuroendocrine tumors can be treated with regimens for neuroendocrine tumors.